Stephanie Davis' Stock Ratings

Barclays Analyst

Stephanie Davis is an analyst at Barclays. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/28/2024

Overall Average Return

-19.2%

Smart Score

39.1%

Overall Average Return Percentile

12th

Number of Ratings

54
Buy NowGet Alert
06/28/2024ACCDBuy Now
Accolade
$3.6550.68%$11 → $5.5MaintainsEqual-WeightGet Alert
05/20/2024GDRXBuy Now
GoodRx Holdings
$7.6131.41%$9 → $10MaintainsOverweightGet Alert
04/26/2024LHBuy Now
Laboratory Corp
$203.514.66%$234 → $213MaintainsEqual-WeightGet Alert
04/25/2024DGXBuy Now
Quest Diagnostics
$136.885.2%$138 → $144MaintainsEqual-WeightGet Alert
03/01/2024WWBuy Now
WW International
$1.1926.05%$8 → $1.5MaintainsUnderweightGet Alert
02/28/2024RCMBuy Now
R1 RCM
$12.5611.46%$14 → $14DowngradeOverweight → Equal-WeightGet Alert
02/23/2024TALKBuy Now
Talkspace
$2.3030.43%$2.5 → $3MaintainsEqual-WeightGet Alert
01/22/2024CPSIBuy Now
CPSI
$12 → $10MaintainsEqual-WeightGet Alert
01/03/2024OPRXBuy Now
OptimizeRx
$10.1048.51% → $15Initiates → Equal-WeightGet Alert
01/03/2024PHRBuy Now
Phreesia
$21.2036.79% → $29Initiates → OverweightGet Alert
01/03/2024LHBuy Now
Laboratory Corp
$203.519.09% → $222Initiates → Equal-WeightGet Alert
01/03/2024RCMBuy Now
R1 RCM
$12.5611.46% → $14Initiates → OverweightGet Alert
01/03/2024TALKBuy Now
Talkspace
$2.308.7% → $2.5Initiates → Equal-WeightGet Alert
01/03/2024MDRXBuy Now
Veradigm
→ $11Initiates → Equal-WeightGet Alert
01/03/2024CORBuy Now
Cencora
$225.307.41% → $242Initiates → OverweightGet Alert
01/03/2024CAHBuy Now
Cardinal Health
$98.2119.13% → $117Initiates → OverweightGet Alert
02/23/2023TDOCBuy Now
Teladoc Health
$9.78247.65% → $34UpgradeMarket Perform → OutperformGet Alert
02/08/2023PINCBuy Now
Premier
$18.67124.96%$46 → $42MaintainsOutperformGet Alert
01/05/2023PHRBuy Now
Phreesia
$21.2083.96%$34 → $39MaintainsOutperformGet Alert
01/05/2023PGNYBuy Now
Progyny
$28.3819.8%$59 → $34DowngradeOutperform → Market PerformGet Alert
12/09/2022PHRBuy Now
Phreesia
$21.2060.38%$31 → $34UpgradeMarket Perform → OutperformGet Alert
12/02/2022VEEVBuy Now
Veeva Sys
$183.0127.32%$242 → $233MaintainsOutperformGet Alert
11/09/2022HCATBuy Now
Health Catalyst
$6.39166.04%$20 → $17MaintainsOutperformGet Alert
11/09/2022TALKBuy Now
Talkspace
$2.30-56.52%$2 → $1MaintainsMarket PerformGet Alert
11/09/2022RCMBuy Now
R1 RCM
$12.5627.39%$35 → $16MaintainsOutperformGet Alert
10/26/2022NXGNBuy Now
NextGen Healthcare
$24 → $25MaintainsOutperformGet Alert
10/07/2022ACCDBuy Now
Accolade
$3.65256.16%$8 → $13MaintainsMarket PerformGet Alert
09/08/2022PHRBuy Now
Phreesia
$21.2046.23%$27 → $31MaintainsMarket PerformGet Alert
09/01/2022VEEVBuy Now
Veeva Sys
$183.0132.23%$268 → $242MaintainsOutperformGet Alert
08/09/2022GDRXBuy Now
GoodRx Holdings
$7.6144.55%$8 → $11MaintainsMarket PerformGet Alert
06/07/2022HQYBuy Now
HealthEquity
$86.20-11.83%$67 → $76MaintainsOutperformGet Alert
06/03/2022PHRBuy Now
Phreesia
$21.203.77%$29 → $22MaintainsMarket PerformGet Alert
05/18/2022DOCSBuy Now
Doximity
$27.97139.54%$72 → $67MaintainsOutperformGet Alert
05/11/2022HCATBuy Now
Health Catalyst
$6.39244.29%$48 → $22MaintainsOutperformGet Alert
05/09/2022TRHCBuy Now
Tabula Rasa HealthCare
$11 → $4MaintainsMarket PerformGet Alert
05/04/2022NXGNBuy Now
NextGen Healthcare
$22 → $24MaintainsOutperformGet Alert
05/04/2022TALKBuy Now
Talkspace
$2.30-13.04%$3 → $2MaintainsMarket PerformGet Alert
03/31/2022PHRBuy Now
Phreesia
$21.2036.79%$41 → $29MaintainsMarket PerformGet Alert
03/03/2022VEEVBuy Now
Veeva Sys
$183.0146.44%$282 → $268MaintainsOutperformGet Alert
03/03/2022CPSIBuy Now
CPSI
$35 → $38MaintainsOutperformGet Alert
03/03/2022MDRXBuy Now
Veradigm
$22 → $24MaintainsOutperformGet Alert
03/02/2022HCATBuy Now
Health Catalyst
$6.39651.17%$64 → $48MaintainsOutperformGet Alert
03/01/2022GDRXBuy Now
GoodRx Holdings
$7.61333.64%$49 → $33MaintainsOutperformGet Alert
02/16/2022CPSIBuy Now
CPSI
$37 → $35MaintainsOutperformGet Alert
01/25/2022MDRXBuy Now
Veradigm
$19 → $22UpgradeMarket Perform → OutperformGet Alert
01/06/2022PHRBuy Now
Phreesia
$21.2093.4%$57 → $41DowngradeOutperform → Market PerformGet Alert
01/06/2022NXGNBuy Now
NextGen Healthcare
UpgradeMarket Perform → OutperformGet Alert
01/06/2022VEEVBuy Now
Veeva Sys
$183.01UpgradeMarket Perform → OutperformGet Alert
12/21/2021CERNBuy Now
Cerner
$88 → $95DowngradeOutperform → Market PerformGet Alert
12/10/2021PHRBuy Now
Phreesia
$21.20168.87%MaintainsOutperformGet Alert
12/02/2021VEEVBuy Now
Veeva Systems
$183.0154.09%MaintainsMarket PerformGet Alert
11/19/2021TDOCBuy Now
Teladoc Health
$9.781873.42%MaintainsOutperformGet Alert
11/16/2021TALKBuy Now
Talkspace
$2.30DowngradeOutperform → Market PerformGet Alert
11/11/2021GDRXBuy Now
GoodRx Holdings
$7.61543.89%MaintainsOutperformGet Alert